Triomics
Generative AI for Oncology EHRs
Healthcare
YC W21
- Headquarters
- San Francisco, California
- Employees
- 50
- Founded
- 2021
- Business Model
- B2B
- Website
- triomics.com
- Total Funding
- $15.0M
- Last Round
- $15.0M Series AMay 2024
About
Triomics is helping cancer care providers by reducing the burden associated with manually reviewing patient charts. Utilizing our OncoLLM™—a family of oncology-focused language models—we are able to accelerate clinical trial enrollment, power quality improvement projects, and address many other key strategic priorities.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account